These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 12219430)

  • 21. Health beliefs of women with and without breast cancer seeking genetic cancer risk assessment.
    MacDonald DJ; Sarna L; Uman GC; Grant M; Weitzel JN
    Cancer Nurs; 2005; 28(5):372-9; quiz 380-1. PubMed ID: 16192828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In familial breast or ovarian carcinoma: normal cancer prevention is not enough].
    Riem L
    MMW Fortschr Med; 2004 Apr; 146(15):12. PubMed ID: 15373015
    [No Abstract]   [Full Text] [Related]  

  • 23. Genetic testing for breast cancer susceptibility: Polish women's attitudes.
    Braczkowski R; Nowakowska-Zajdel E; Zubelewicz B; Muc-Wierzgon M; Romanowski W
    J Exp Clin Cancer Res; 1998 Sep; 17(3):299-302. PubMed ID: 9894765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer risk elements and nurse practitioners' knowledge, use, and perceived comfort level of breast cancer risk assessment.
    Edwards QT; Maradiegue A; Seibert D; Saunders-Goldson S; Humphreys S
    J Am Acad Nurse Pract; 2009 May; 21(5):270-7. PubMed ID: 19432911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct-to-patient BRCA1 testing: the Twoj Styl experience.
    Gronwald J; Huzarski T; Byrski T; Debniak T; Metcalfe K; Narod SA; Lubiński J
    Breast Cancer Res Treat; 2006 Dec; 100(3):239-45. PubMed ID: 16807675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
    Chompret A
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast cancer attitudes, knowledge, and screening behavior in women with and without a family history of breast cancer.
    Hailey BJ; Carter CL; Burnett DR
    Health Care Women Int; 2000 Dec; 21(8):701-15. PubMed ID: 11813762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ethical issues related to BRCA gene testing in orthodox Jewish women.
    Mor P; Oberle K
    Nurs Ethics; 2008 Jul; 15(4):512-22. PubMed ID: 18515440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of a randomized study of telephone versus in-person breast cancer risk counseling.
    Helmes AW; Culver JO; Bowen DJ
    Patient Educ Couns; 2006 Dec; 64(1-3):96-103. PubMed ID: 16427245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary breast cancer. Risk assessment of patients with a family history of breast cancer.
    Warner E; Heisey RE; Goel V; Carroll JC; McCready DR
    Can Fam Physician; 1999 Jan; 45():104-12. PubMed ID: 10889863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of a cancer risk assessment clinic.
    Med Manag Netw; 1999 Jul; 7(7):6-10. PubMed ID: 10538699
    [No Abstract]   [Full Text] [Related]  

  • 32. [Counselling, genetic testing and prevention in women with hereditary breast- and ovarian cancer. Interdisciplinary recommendations of the consortium "Hereditary Breast- and Ovarian Cancer" of the German Cancer AiD].
    Schmutzler R; Schlegelberger B; Meindl A; Gerber WD; Kiechle M;
    Zentralbl Gynakol; 2003 Dec; 125(12):494-506. PubMed ID: 14755360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk.
    Wakefield CE; Meiser B; Homewood J; Peate M; Taylor A; Lobb E; Kirk J; Young MA; Williams R; Dudding T; Tucker K;
    Breast Cancer Res Treat; 2008 Jan; 107(2):289-301. PubMed ID: 17333332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 'A low risk is still a risk': exploring women's attitudes towards genetic testing for breast cancer susceptibility in order to target disease prevention.
    Henneman L; Timmermans DR; Bouwman CM; Cornel MC; Meijers-Heijboer H
    Public Health Genomics; 2011; 14(4-5):238-47. PubMed ID: 20090298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Five families living with hereditary breast and ovarian cancer risk.
    Norris J; Spelic SS; Snyder C; Tinley S
    Clin J Oncol Nurs; 2009 Feb; 13(1):73-80. PubMed ID: 19193551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An informed decision? Breast cancer patients and their knowledge about treatment.
    Fagerlin A; Lakhani I; Lantz PM; Janz NK; Morrow M; Schwartz K; Deapen D; Salem B; Liu L; Katz SJ
    Patient Educ Couns; 2006 Dec; 64(1-3):303-12. PubMed ID: 16860523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How making a risk estimate can change the feel of that risk: shifting attitudes toward breast cancer risk in a general public survey.
    Fagerlin A; Zikmund-Fisher BJ; Ubel PA
    Patient Educ Couns; 2005 Jun; 57(3):294-9. PubMed ID: 15893211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic risk assessment for breast and ovarian cancer.
    O'Rourke Tiffen J; Pfeifer K; Fishman DA
    Adv Nurse Pract; 2003 Oct; 11(10):40-8. PubMed ID: 14601495
    [No Abstract]   [Full Text] [Related]  

  • 40. [Recommendations for treatment of individuals at risk for hereditary breast and ovarian carcinoma].
    Radulović S; Branković-Magić M; Janković R; Ristanović M
    Srp Arh Celok Lek; 2003; 131(7-8):345-50. PubMed ID: 14692152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.